4Fidel PL Jr.The protective immune response against vaginal candidiasis:lessons learned from clinical studies and animal model.Infect Immun,2003,71(2):956-963.
5Centers for Disease Control and Prevention.Sexually transmitted diseases treatment guidelines 2002.Recommendations and Reports,2002.45-47.
6左绪磊.妇产科感染[M].北京:人民卫生出版社,2001.223-230.
7Gilles RG, Moni F. Infections diseases in obstetrics and gynecology. 4th ed. Omaha . U.S.A: IDI Publications, 1999.464-472
8Lockhart, Reed BD, Pierson CL, et al. Most frequent scenario for recurrent Candida vaginitis is strain maintenance with substrain shuffling :demonstration by sequential DNA fingerprinting with probes Ca3 C1 and CARE2. J Clin Microbiol, 1996,34(4):767-777
9Odds FC. Epidemiology of vaginal candida infection: significance of numbers of vaginal yeasts and their biotypes. Eur J Obstet Gynecol Reprod Biol, 1987,25(1):53-56
10Spinillo A, Pizzoli G, Colonnal L, et al. Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis. Obstet Gynecol, 1993,81(5):721-727
